OY 3 for rals coaguchek at ANN arbor, chillicothe, saginaw, detroit
Active Awarded Last action
- Contract number
- 36C25026N0253
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $100,815.00 Potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation has been awarded a delivery order valued at $100,815 for the provision of CoaguCheck supplies and services across four Department of Veterans Affairs facilities in Michigan: Ann Arbor, Chillicothe, Saginaw, and Detroit. The contract, effective January 1, 2026, with a completion date of December 31, 2026, is issued without a set-aside designation under the In Vitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule. The work is performed in Castleton, Indiana, and funded through Veterans Integrated Service Network 10, a component of the Veterans Health Administration responsible for delivering healthcare services to veterans in the Midwest region.
This delivery order represents a continuation of Roche Diagnostics' substantial relationship with the Department of Veterans Affairs, where the company supplies diagnostic testing equipment, reagents, and related services across multiple VISN networks. CoaguCheck is a point-of-care testing system commonly used for monitoring anticoagulation therapy in patient populations. As a firm fixed-price contract, the pricing terms are established under the parent GSA Schedule agreement, enabling the VA to efficiently procure diagnostic technologies through pre-negotiated terms while maintaining cost control throughout the contract period.
Quick answers
Who was awarded contract 36C25026N0253?
36C25026N0253 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 1, 2026.
How much is contract 36C25026N0253 worth?
The government has obligated $0 on 36C25026N0253. Its potential value, with all options, is $100,815.
Is contract 36C25026N0253 an order under another contract?
Yes. 36C25026N0253 is a delivery order under 36F79722D0128, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25026N0253 competed?
The extent of competition for 36C25026N0253 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award